Inventor · disambiguated record
Ronan O'Hagan
Also filed as: O'HAGAN RONAN · O'HAGAN RONAN C · OHAGAN RONAN
11 granted patents·8 pending applications·46 citations·filing 2004–2025
88Inventor score
Top patents by PatentIndex Score
19 records- 0195US11053294B2Masked cytokine polypeptidesXILIO DEV INC·Filed 2020·Granted Jul 6, 2021·13 cites·15 claims
- 0292US11866476B2Masked IL-2-Fc fusion polypeptidesXILIO DEV INC·Filed 2022·Granted Jan 9, 2024·1 cites·10 claims
- 0391US9879083B2Anti-Notch3 antibodiesAVEO PHARMACEUTICALS INC·Filed 2013·Granted Jan 30, 2018·12 cites·23 claims
- 0490US11718655B2Masked interleukin-12 polypeptidesXILIO DEV INC·Filed 2022·Granted Aug 8, 2023·1 cites·9 claims
- 0589US10745476B2Anti-NOTCH3 antibodiesAVEO PHARMACEUTICALS INC·Filed 2018·Granted Aug 18, 2020·5 cites·28 claims
- 0683US7544476B1Identifying cancers sensitive to treatment with inhibitors of notch signalingAVEO PHARMACEUTICALS INC·Filed 2009·Granted Jun 9, 2009·11 cites·9 claims
- 0775US11827686B2Masked cytokine polypeptidesXILIO DEV INC·Filed 2021·Granted Nov 28, 2023·0 cites·9 claims
- 0875US11827685B2Masked cytokine polypeptidesXILIO DEV INC·Filed 2021·Granted Nov 28, 2023·0 cites·18 claims
- 0974US2022002370A1Masked cytokine polypeptidesXILIO DEV INC·Filed 2019·Application pending·0 cites
- 1073US2025289884A1Anti-notch3 antibodiesAVEO PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1169US12269877B2Anti-notch3 antibodiesAVEO PHARMACEUTICALS INC·Filed 2020·Granted Apr 8, 2025·0 cites·18 claims
- 1264US7556796B2Directed complementationAVEO PHARMACEUTICALS INC·Filed 2006·Granted Jul 7, 2009·2 cites·12 claims
- 1351US7622630B2Chimeric cancer modelsAVEO PHARMACEUTICALS INC·Filed 2004·Granted Nov 24, 2009·1 cites·6 claims
- 1447US2007042980A1Gp131: methods and compositions for treating cancerO'HAGAN RONAN C·Filed 2004·Application pending·0 cites
- 1545US2007275376A1Tumor-Specific Expression of Reporter GenesHEYER JOERG·Filed 2004·Application pending·0 cites
- 1643US2006222590A1Directed complementationROBINSON MURRAY·Filed 2005·Application pending·0 cites
- 1741US2008234304A1N3-Pyridyl-Thiamine And Its Use In Cancer TreatmentsAVEO PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1839US2018044418A1Combination of a pd-1 antagonist and vorinostat for treating cancerMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 1938US2006222589A1Directed complementationROBINSON MURRAY·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →